SCHEMBL7800969

SCHEMBL7800969

O=C(NCCc1ccccc1)C(CSSCC(NS(=O)(=O)c1ccccc1)C(=O)NCCc1ccccc1)NS(=O)(=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 6/20 0.55
MMP9 P14780 5/20 0.55
MMP8 P22894 1/20 0.55
MMP12 P39900 1/20 0.55
MMP14 P50281 1/20 0.55
HTT P42858 1/20 0.47
ATM Q13315 1/20 0.47
ADAMTS4 O75173 1/20 0.47
ALDH1A1 P00352 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
ITGB3 P05106 1/20 0.46
ITGA2B P08514 1/20 0.46
CA2 P00918 3/20 0.46
CA1 P00915 3/20 0.46
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46
MAPT P10636 1/20 0.45
CA5A P35218 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793406 0.86 POLB (0.49) MMP2MMP8CYP2C9CYP2C19CA2
SCHEMBL7803203 0.85 POLB (0.51) MMP8CYP2C9CYP2C19CA2CA1
SCHEMBL7793404 0.85 F10 (0.48) MMP2MMP9MMP8HTTCYP2C9
SCHEMBL7798914 0.77 POLB (0.48) MMP2MMP9ALDH1A1CYP2C9CYP2C19
SCHEMBL7793435 0.77 CA12 (0.52) MMP8ALDH1A1CYP2C9CYP2C19CA2
SCHEMBL7793390 0.76 KMT2A (0.57) ALDH1A1CA2CA12CA9
SCHEMBL7799262 0.75 POLB (0.52) MMP8CYP2C9CYP2C19ITGB3ITGA2B
SCHEMBL6021548 0.74 CTSL (0.45) MMP2MMP9MMP8MMP12MMP14
SCHEMBL29376103 0.74 BDKRB1 (0.52) MMP2MMP9MMP8MMP12MMP14
SCHEMBL8707457 0.74 ALDH1A1 (0.63) MMP2MMP9MMP8MMP12MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed